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A. SPECIFIC AIMS 
In recent years, the application of magnetic nanoparticles (MNPs) in magnetic fluid hyperthermia 
(MFH) has emerged as a viable alternative to radiotherapy, chemotherapy, and surgery for the 
treatment of a wide variety of cancerous tumors.  The MFH procedure, which requires raising the 
temperature of the tumor to 42 – 45o C, has become more prevalent in Europe and Asia as compared 
to the rest of the world.  Current treatments typically use superparamagnetic iron oxide nanoparticles 
(SPIONs) as the magnetic mediator; however, in today’s day and age where efficiency is always a 
matter of concern, there is a push for multi-purposed materials.  It has been found that a core-shell 
nanoparticle system has the capability to generate a larger specific absorption rate (SAR) than standard 
nanoparticles [1].  We proposed to develop core-shell magnetic nanoparticles consisting of a 
gadolinium-doped iron-oxide core surrounded by an iron-oxide shell which will have properties not 
only suited for use as agents in MFH, but also as contrast agents for magnetic resonance imaging (MRI) 
The concept of MFH is based on the high heat-sensitivity of malignant neoplastic tissue when 
compared to that of normal human cells.  For local magnetic fluid hyperthermia, MNPs in a carrier fluid 
are delivered to the tumor site via direct injection or targeted to the site through the use of tumor 
specific antibodies.   Once inside the tumor, the nanoparticles are exposed to an alternating magnetic 
field which causes heating of the MNPs due to magnetic relaxation (both Néel and Brownian 
mechanisms) as well as hysteretic losses. Such a rise in temperature is enough to kill cancer cells while 
leaving healthy tissue unharmed. 
 Specific Aim #1:  Development of a method to synthesize Fe3-xGdxO4/Fe3O4 core/shell 
nanoparticles (CSNPs).  Our plan is to develop a method by which Fe3-xGdxO4 magnetic nanoparticles 
synthesized through a standard coprecipitation method can be coated with an Fe3O4 shell.  The 
purpose of this is to develop a core/shell system which has increased magnetic susceptibility due to the 
presence of gadolinium but preserves the biocompatibility of Fe3O4-based systems. 
 Specific Aim #2:  Investigation of the structural characteristics of the synthesized                     
Fe3-xGdxO4/Fe3O4 samples.  The Fe3-xGdxO4/Fe3O4 CSNPs will be characterized by X-ray diffraction 
(XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM) for phase 
identification as well as the determination of particle morphology.  
 Specific Aim #3:  Investigation of the magnetic properties of the proposed nanoparticles 
through the use of dc- and ac-magnetometry.  In order to determine the magnetic properties of the 
Fe3-xGdxO4/Fe3O4 CSNPs we will perform temperature-dependent magnetic experiments using the 
magnetometers of our collaborators at South Dakota State University and Wayne State University 
 Specific Aim #4:  Investigation of the magnetic heating of an aqueous suspension of the 
nanoparticles under an alternating magnetic field.  These studies must be performed for a number of 
reasons which include the determination of the temperature dependent specific absorption rate (SAR) 
of the aqueous Fe3-xGdxO4/Fe3O4 CSNP solution. 
 
 Specific Aim #5:  Specific Aim # 5: To investigate image contrast properties in magnetic 
resonance imaging.  Using the Magnetic Resonance Imaging capabilities of our collaborators (Insight 
Institute for Neurosurgery and Neuroscience) we plan to perform in vitro investigations of how 
aqueous solutions of Fe3-xGdxO4/Fe3O4 CSNP may provide contrast enhancement in functional magnetic 
resonance imaging. 
B. BACKGROUND AND SIGNIFICANCE 
 Magnetic hyperthermia has been widely considered as a possible non-invasive treatment for 
cancerous solid tumors since its 
introduction in 1957 when Gilchrist 
et al [2] used 20—100 nm particles 
of -Fe2O3 in conjunction with an 
alternating magnetic field in the MHz 
range to heat various tissue samples.  
In broad terms, MFH involves the 
dispersion of magnetic nanoparticles 
throughout a tumor site and the 
exposure of these nanoparticles to a 
small (~10-3 T) time-varying magnetic 
field in the RF range.  The relaxation 
of the magnetic nanoparticles into 
the field causes dispersion of heat 
due to various methods of energy 
loss (Néel relaxation, Brownian 
relaxation, hysteretic losses, etc.).  
This heat is conducted to the nearby 
cancerous tissue whereby, if the 
temperature can be maintained 
above a threshold of 42˚C – 46˚C for 
a time of not less than 30 minutes, 
the cancer will be destroyed via 
necrosis, coagulation and carbonization.  The most commonly used materials for this treatment are 
mono-metallic oxides such as -Fe2O3 and Fe3O4 (because of their abundance and biocompatibility.   
In general, heat production via magnetic materials in alternating magnetic fields arises due to 
two general classes of materials:  multi-domain ferro(ferri-)magnetic systems and single-domain 
superparamagnetic systems.  In the former, heat production originates primarily through hysteretic 
power losses.  For superparamagnetic nanoparticles, heating is accomplished through losses as the 
particles’ superspins align with the external field through the Néel mechanism (rotation of the 
magnetic moment within a fixed particle) and Brownian motion (physical rotation of the particle 
with a fixed moment), the latter of which can contribute to the dissipation of energy by means of 
friction [2].  Typically, MFH is accomplished using superparamagnetic iron oxide nanoparticles or 
SPIONs (Fe3O4 and -Fe2O3) due to their relative biocompatibility [4 – 8]; however, the specific 
absorption rate (SAR) of magnetic liquids based on these materials is limited by their saturation 
magnetization.  It is our hope that through doping the core with gadolinium we can increase the 
saturation magnetization of the particles while preserving their biocompatibility and also provide a 
material that can be used not only for MFH but for MRI contrast enhancement as well (many MRI 
contrast agents are based on gadolinium chelates [9]). 
C. SUMMARY OF EXPERIMENTAL DESIGN AND METHODS 
Synthesis of multicore nanoparticles.  The synthesis of Fe3-xGdxO4 magnetic nanoparticles 
nanoparticles will be accomplished via the wet-chemical coprecipitation of iron and gadolinium 
salts.  The resulting powders will then be coated with Fe3O4 through various methods outlined in 
the literature to determine the best suited method for our purpose [10 – 13]. 
Structural and morphological characterization.  Samples synthesized via the method above will 
be analyzed through x-ray diffraction in order to confirm the structural nature and average size of 
the nanoparticles.  In addition, scanning and transmission electron microscopy will be used to 
further investigate the phase and morphology of the samples. 
Magnetic characterization.  Using a Quantum Design Model 6000 Physical Properties 
Measurement system (at Wayne State University) and a Quantum Design Versalab magnetometer 
(South Dakota State University), we will investigate the ac- and dc- magnetic properties of the 
synthesized samples.  We will specifically look at the temperature-dependent properties in order to 
determine the Curie temperature of the samples. 
Analysis of the heating characteristics.  The heating characteristics of each sample will be 
measured using Kettering University’s Ambrell EASYHEAT system.  Specifically, we are interested in 
determining two main points:  The specific absorption rate (SAR) of the sample as it heats from 
room temperature, and the samples ability to hold a constant temperature in the range of 42—
46˚C while constantly being driven by the ac magnetic field.  The SAR is defined to be the power 
dissipated by a magnetic material subjected to an alternating magnetic field.  For MFH, the SAR is 
related to the specific heat of the solvent in which the magnetic nanoparticles are suspended, the 
weight fraction of the magnetic element, and the slope of the temperature vs. time curve. 
D. POTENTIAL SOURCES OF EXTERNAL FUNDING 
The preliminary data obtained from this project presents itself well to solicitation of funds from 
both the National Institutes of Health (NIH) and the National Science Foundation (NSF).  For 
example, the Biomaterials program (BMAT) within the NSF’s Division of Materials Research (DMR) 
which supports fundamental research related to (1) biological materials, (2) biometric, bioinspired, 
and bioenabled materials, (3) synthetic materials intended for applications in contact with 
biological systems, and (4) the processes through which nature produces biological materials (taken 
from www.nsf.gov) would be ideal sources of future external funding for this research. 
 
 
 
E. BUDGET 
We anticipate the following expenses for this project 
Budgeted Item Amount 
Undergraduate Research Assistantships $4,000.00 
Materials and Lab Supplies $1,500.00 
Publication Charges $500.00 
TOTAL $6,000.00 
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